Targeting Glutamine Metabolism in MYC Driven Atypical Teratoid Rhabdoid Tumors |
The Johns Hopkins University School of Medicine / Jeffrey Rubens, MD |
Young Investigator Grants |
2017 |
Maryland |
Characterization of Novel OTX2-semaphorin Gene Signaling Pathways Regulating the ‘Grow and Go’ Arms of Highly Aggressive Medulloblastomas |
University of Manitoba / Tamra Werbowetski-Ogilvie, PhD |
Innovation Grants |
2017 |
Manitoba |
Identifying Disease Mechanisms and Therapeutic Opportunities in Pediatric Low-grade Gliomas Driven by MYB-QKI Fusions |
Dana-Farber Cancer Institute / Cecile Rouleau, PhD |
Young Investigator Grants |
2017 |
Massachusetts |
3-D Printed Self-fitting Shape Memory Bone Grafts for Smart Pediatric Skeletal Reconstruction |
University of Massachusetts Medical School / Jie Song, PhD |
Innovation Grants |
2017 |
Massachusetts |
Role of N6-Methyladenosine (m6A) mRNA Modification Pathway in Neuroblastoma |
Boston Children’s Hospital / Shuibin Lin, PhD |
Young Investigator Grants |
2017 |
Massachusetts |
Reversing mSWI/SNF (BAF) Complex Misassembly and Genomic Targeting in Human Synovial Sarcoma |
Dana-Farber Cancer Institute / Cigall Kadoch, PhD |
'A' Award Grants |
2017 |
Massachusetts |
Understanding the Mechanisms of HOX Gene Regulation in Normal and Leukemic Hematopoietic Stem Cells to Identify New Therapies for Pediatric AML |
Boston Children’s Hospital / Anne Robertson, PhD |
Young Investigator Grants |
2017 |
Massachusetts |
Mechanisms of OTX2 Mediated Chromatin Regulation in Medulloblastoma |
Massachusetts General Hospital / Miguel Rivera, MD |
Innovation Grants |
2017 |
Massachusetts |
Targeting BRD9 in Sarcoma |
Dana-Farber Cancer Institute / Scott Armstrong, MD/PhD |
Innovation Grants |
2017 |
Massachusetts |
Novel Approaches to AML Differentiation Therapy |
Dana-Farber Cancer Institute / Andrew Lane, MD/PhD |
'A' Award Grants |
2017 |
Massachusetts |